X-376 T3550
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Ensartinib (X-396) is an orally available small molecule inhibitor of the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) with potential antineoplastic activity. Upon oral administration, X-396 binds to and inhibits ALK kinase, ALK fusion protei
CAS nr:
1365267-27-1
Purity:
98%
Molecular Weight:
547,41
SMILES:
c1(cc(c(nn1)N)O[C@H](C)c1c(c(ccc1Cl)F)Cl)C(=O)Nc1ccc(cc1)C(=O)N1CCN(CC1)C
Formula:
C25H25Cl2FN5O3
Pathway:
Tyrosine Kinase/Adaptors,Tyrosine Kinase/Adaptors,Angiogenesis
Target:
c-Met/HGFR,ALK,ALK
